| Standard Report | Premium Report | |
|---|---|---|
| Current State of the Industry |  |
|
| Market Size (industry trends) | |
|
| Market Forecast (5-year projection) | |
|
| Products/Services Breakdown | |
|
| Revenue per State | |
|
| Financial Metrics | |
|
| Salary & Compensation Statistics | |
|
| Public Company Information | |
|
| Key Private Companies | |
|
| Government Vendors | |
|
| Instant Download - Available immediately upon purchase | |
|
Download both PDF and Excel
|
|
|
| Download now: |
2025 U.S. Industry Statistics & Market Forecast - Pharmaceutical and Medicine Manufacturing
Market Size & Industry Statistics
The total U.S. industry market size for Pharmaceutical and Medicine Manufacturing:
Industry statistics cover all companies in the United States, both public and private, ranging in size from small businesses to market leaders.
In addition to revenue, the industry market analysis shows information on employees, companies, and average firm size.
Investors, banks, and business executives use growth rates and industry trends to understand the market outlook and opportunity.
| Statistics | 2020 2021 2022 2023 2024 | |
|---|---|---|
| Market Size (Total Sales/Revenue) |
Order at top of page | |
| Total Firms | ||
| Total Employees | ||
| Average Revenue Per Firm | ||
| Average Employees Per Firm | ||
| Average Revenue Per Employee | ||
Market Forecast
Market forecasts show the long term industry outlook and future growth trends. The following extended five-year forecast projects both short-term and long-term trends.
| Forecast / Industry Outlook | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| Market Forecast ($ millions) | |||||
| Projected Industry Growth Rate (%) | |||||
Industry Insights
Major trends affect the Pharmaceutical and Medicine Manufacturing industry include:- Rising demand for personalized medicine
- Shift towards biologics and specialty drugs
- Increased investment in research and development
- Regulatory changes impacting approvals and compliance
- Growth in aging populations globally
- Expansion of healthcare in emerging markets
- Technological advancements in drug development and manufacturing
- Use of artificial intelligence and machine learning
- Focus on sustainable and green manufacturing processes
- Impact of global supply chain disruptions
- Increased scrutiny on pricing and affordability of drugs
- Collaborations and partnerships in the industry
- Rise of digital health and telemedicine
- Growing importance of patient-centric healthcare services
- Enhanced focus on cybersecurity and data protection
U.S. Geographic Distribution: Revenue Statistics by State
Market Size by State ($ millions) indicates how the industry's competition is distributed throughout the country. State-level information can identify areas with higher and lower industry market share than average.
Income Statement (Average Financial Metrics)
Financial metrics provide a snapshot view of a benchmark "average" company. Key business metrics show revenue and operating costs. The data collected covers both public and private companies.| Industry Average | Percent of Sales (Industry Benchmark) |
|
|---|---|---|
| Total Revenue | Order at top of page |
|
| Operating Revenue | ||
| Cost of Goods Sold | ||
| Gross Profit | ||
Operating Expenses | ||
| Pension, profit sharing plans, stock, annuity | ||
| Repairs | ||
| Rent paid on business property | ||
| Charitable Contributions | ||
| Depletion | ||
| Domestic production activities deduction | ||
| Advertising | ||
| Compensation of officers | ||
| Salaries and wages | ||
| Employee benefit programs | ||
| Taxes and Licenses | ||
| Bad Debts | ||
| Depreciation | ||
| Amortization | ||
| Other Operating Expenses | ||
| Total Operating Expenses | ||
| Operating Income | ||
| Non-Operating Income | ||
| EBIT (Earnings Before Interest and Taxes) | ||
| Interest Expense | ||
| Earnings Before Taxes | ||
| Income Tax | ||
| Net Profit Net Income | ||
Financial Ratio Analysis
Financial ratio information can be used to benchmark how a Pharmaceutical and Medicine Manufacturing company compares to its peers. Accounting statistics are calculated from the industry-average for income statements and balance sheets.| Profitability & Valuation Ratios | Industry Average |
|---|---|
| Company valuation can be measured based on the firm's own performance, as well as in comparison against its industry competitors. These metrics show how the average company in the Pharmaceutical and Medicine Manufacturing industry is performing. | |
| Profit Margin Gross Profit Margin, Operating Profit Margin, and Net Profit Margin. Show company earnings relative to revenues. |
|
| Return on Equity (ROE) Return on Equity (ROE) is net income as a percentage of shareholders' equity. Shareholders' Equity is defined as the company's total assets minus total liabilities. ROE shows how much profits a company generates with the money shareholders invested (or with retained earnings). |
|
| Return on Assets (ROA) Return on Assets (ROA) is net income relative to total assets. The market research on Pharmaceutical and Medicine Manufacturing measures how efficiently the company leverages its assets to generate profit. ROA is calculated as Net Income divided by Total Assets. |
|
| Liquidity Ratios | Industry Average |
|---|---|
| Bankers and suppliers use liquidity to determine creditworthiness and identify potential threats to a company's financial viability. | |
| Current Ratio Measures a firm's ability to pay its debts over the next 12 months. |
|
| Quick Ratio (Acid Test) Calculates liquid assets relative to liabilities, excluding inventories. |
|
| Efficiency Ratios - Key Performance Indicators | Industry Average |
|---|---|
| Measure how quickly products and services sell, and effectively collections policies are implemented. | |
| Receivables Turnover Ratio If this number is low in your business when compared to the industry average in the research report, it may mean your payment terms are too lenient or that you are not doing a good enough job on collections. |
|
| Average Collection Period Based on the Receivables Turnover, this estimates the collection period in days. Calculated as 365 divided by the Receivables Turnover |
|
| Inventory Turnover A low turnover rate may point to overstocking, obsolescence, or deficiencies in the product line or marketing effort. |
|
| Fixed-Asset Turnover Generally, higher is better, since it indicates the business has less money tied up in fixed assets for each dollar of sales revenue. |
|
Compensation & Salary Surveys for Employees
Compensation statistics provides an accurate assessment of industry-specific jobs and national salary averages. This information can be used to identify which positions are most common, and high, low, and average annual wages.| Title | Percent of Workforce | Bottom Quartile | Average (Median) Salary | Upper Quartile |
|---|---|---|---|---|
| Management Occupations | 12% | Order at top of page |
||
| Chief Executives | 0% | |||
| General and Operations Managers | 2% | |||
| Operations Specialties Managers | 5% | |||
| Business and Financial Operations Occupations | 8% | |||
| Business Operations Specialists | 7% | |||
| Architecture and Engineering Occupations | 5% | |||
| Life, Physical, and Social Science Occupations | 14% | |||
| Life Scientists | 5% | |||
| Office and Administrative Support Occupations | 8% | |||
| Production Occupations | 34% | |||
| Other Production Occupations | 29% | |||
| Chemical Processing Machine Setters, Operators, and Tenders | 9% | |||
| Chemical Equipment Operators and Tenders | 8% | |||
| Packaging and Filling Machine Operators and Tenders | 10% | |||
| Packaging and Filling Machine Operators and Tenders | 10% | |||
| Transportation and Material Moving Occupations | 5% | |||
Pharmaceutical and Medicine Manufacturing Competitor Landscape & Key Companies [PREMIUM]
The most influential companies in the Pharmaceutical and Medicine Manufacturing industry and adjacent industries either have large market share or are developing new business models and methods that could disrupt the status quo. We look at leading and emerging companies in the Pharmaceutical and Medicine Manufacturing industry and adjacent sectors:| Market Leaders: Direct Competitors Companies with the largest market share, focused in this industry |
Market leaders: Diversified Competitors Largest companies that have diversified operations in this and other industries |
| Innovators: Direct Competitors Innovative, Emerging, and Disruptive Companies that may influence the future direction of the industry. |
Innovators: Diversified Competitors Innovators and Disruptors in adjacent industries that may also affect the Pharmaceutical and Medicine Manufacturing industry. |
Source:
Latest Industry News
- Pharmexcil invites Croatia and Austria pharma delegation to explore iPHEX -2025 to enhance bilateral trade - Pharmexcil invites Croatia and Austria pharma delegation to explore iPHEX -2025 to enhance bilateral trade: Shardul Nautiyal, Mumbai Monday, July 7, 2025, 08:00 Hrs [IST] With rep (07/07/2025)
- Top Pharmaceutical Manufacturer IVEN Shines at CPHI China 2025 - CPHI China has long been recognized as a premier platform for connecting the entire pharmaceutical supply chain, from active pharmaceutical ingredients (APIs) and excipients to finished dosage forms, (07/05/2025)
- Sen. Hawley’s pharmaceutical price-control proposal is a national security risk | Opinion - But proposed government price controls risk undermining that progress by weakening domestic innovation and giving Beijing more control over Americans’ health. As the Trump administration and its allies in Congress continue to strengthen our national security, importing European-style price controls is a prescription best left unfilled. (07/05/2025)
- Mexico’s pharma industry eyes growth with 13B pesos promised for drug development and manufacturing - Four Mexican pharmaceutical companies have announced plans to invest more than 13 billion pesos in drug development and manufacturing. (07/04/2025)
- Qatar and Belarus explore joint efforts to develop local veterinary vaccines and fight animal epidemics - Qatar's Ministry of Municipality engages in discussions with Belarusian veterinary experts to enhance animal health through local vaccine production and combat epidemic diseases. The partnership focuses on innovation and strategic collaboration for future animal health initiatives. (07/04/2025)
- Third Party Manufacturing Pharma Business Growth & Market Trends Explained by PharmaHopers - Pharma industry growth fueled by third-party manufacturing, driving efficiency, quality, and market trends for business expansion. (07/01/2025)
- Amid pricing squeeze and market withdrawals, Europe must prioritize generic manufacturing, Teva exec says - Despite the popularity of generic and biosimilar drugs in Europe—the latter of which have struggled to catch on in the U.S.—the continent is suffering from a (07/01/2025)
- Iraq aims to cover 70% of local medicine needs within two years - Iraq aims to cover 70% of its medicine needs via local production in 2 years. Three new cancer drug factories to open this year, says PM's advisor Hamoudi Al-Lami. (06/30/2025)
- Ethiopia Launches New Push for Medicine Self-Reliance - Ethiopia is intensifying efforts to expand domestic pharmaceutical manufacturing, aiming to reduce dependence on imports and build a resilient health system capable of meeting national medical needs, (06/30/2025)
- Hikma to splash $1B on US production and R&D, joining branded drugmakers' investment spree - Despite the slow trickle of updates on President Donald Trump’s proposed pharmaceutical import tariffs, drugmakers have continued to make U.S. manufacturing pledges throughout the year. | Hikma plans to throw down $1 billion by 2030 to expand its manufacturing and R&D firepower in the U. (06/30/2025)
Related Reports
Can't find what you're looking for? We have over a thousand
market research reports.
Ask us and an analyst will help you find what you need.